Ent Wick Ent Wick

ArthronPulse

World 1'st Personal Portable
ELF-EMF Electronic Medicine for
Arthritis Management

Contact Us

Global Population Aging

Population aging has emerged as a significant social issue worldwide.
In South Korea, by 2025, individuals aged 65 and older will constitute over 20% of the total population, ushering in an era of a super-aged society. With the aging population, the management of age-related chronic diseases becomes increasingly critical. Arthritis, in particular, is a major health concern, affecting 38% of individuals aged 50 and older, and 72% of those aged 80 and older. This high prevalence indicates that a substantial portion of the population suffers from this debilitating condition.

  • The Importance of Consistent Joint Care in Slowing Degeneration

    The medical prescriptions and treatment methods for arthritis vary according to its progression stages (1-4).
    During stages 1 and 2, exercise prescriptions are essential, while from stage 3 onwards, procedural and surgical treatments are applied.
    Since the primary objective of all arthritis treatments is to slow down the rate of degeneration, current medical technology has limitations in completely resolving arthritis issues. Additionally, the lifespan of implants used in joint replacement surgeries is limited, making such procedures recommended primarily for individuals aged 70 and older.
    Ultimately, consistent joint care to decelerate the rate of joint degeneration is of utmost importance.

  • The Key to Joint Care: Managing Cartilage Inflammation

    In the case of knee joints, frequent inflammation can occur in the cartilage due to external impacts such as body weight and exercise. During the recovery process from this inflammation, normal cartilage matrix cells decrease, resulting in cartilage damage.
    Therefore, reducing the inflammatory substances in the cartilage and promoting rapid recovery to prevent cartilage damage is a crucial aspect of joint care.

Entwick's Differentiated Joint Inflammation Treatment Device: ArthronPulse

Entwick has analyzed and studied the strengths and weaknesses of six existing non-invasive treatments.
Non-invasive treatment technologies such as ultrasound, TENS (Transcutaneous Electrical Nerve Stimulation), and hyperbaric oxygen therapy have shown some effectiveness in improving joint inflammation, but their efficacy and convenience have limitations.
In contrast, extremely low frequency electromagnetic fields (ELF-EMF), low-level laser therapy (LLLT), and electrical muscle stimulation (EMS) have demonstrated superior therapeutic effects and excellent portability and ease of use.
Thus, these technologies have been selected as the ultimate non-invasive treatment techniques for joint inflammation.

  • Ultrasonic Methods

    1-50Mhz Low Intensity

    Ineffective

    Deep penetration ↓

  • Transcutaneous Electrical Nerve Stimulation (TENS)

    Nerve Slowing Effect

    Therapeutic effects ↓

  • Hyperbaric Oxygen Delivery to Tissues

    Cell activation and recovery effect

    Portability ↓

    Equipment safety ↓

  • Pulsed Electromagnetic Therapy (PEMF)

    Therapy using magnetic fields (cell regeneration)

    Proven effective in multiple studies (FDA cleared)

    Bulk Size

  • Low Level Lasers (LLL)

    650-900 nm IR

    Proven effective in multiple studies (reduces inflammation)

    Deep penetration ↓

  • Electrical Muscle Stimulation (EMS)

    Helps strengthen muscles

  • Cell regeneration

  • Inflammation improvement

  • Muscle strengthening

PEMF / LLL / EMS Utilizing combined functions
Paracrine Effect
Arthritis-inducing factors : IL-1β , TNF-α ↓
Cell division growth factors : IL-10↑

Mechanism of Action for ArthronPulse in Treating Joint Inflammation

ArthronPulse generates extremely low-frequency electromagnetic fields (ELF-EMF) to reduce inflammation-inducing factors (IL-1β, IL-6, PGE2) and increase cell proliferation growth factors (IL-10), thereby rapidly alleviating inflammation in the cartilage.
Additionally, ArthronPulse employs a three-wavelength low-level laser to stimulate the production of intracellular energy substance ATP, aiding in rapid cell recovery and healing.

  • ELF-EMFVery low frequency electromagnetic fields

  • LLL Low Power Lazer(650/830/910nm)

  • Multiple application (knee, shoulder, elbow)

  • Safety Features Wearable Sensor

  • Built-in Battery

  • USBType C Charging

  • Voice guidance features

  • ELF- EMF(Extremely low frequency -Electro Magnetic Fields) Point

    The formation of a three-dimensional electromagnetic field

    Improvement in the cellular absorption rate of minerals, oxygen, and nutrients

    Reduction of toxins, carbon dioxide, and water retention

  • LLLt (Low Level Laser Therapy) Point

    Promotion of vasodilation, blood circulation, and analgesic effects through infrared emission.

    Promotion of ATP production in cells

    Induction of NO and ROS synthesis to improve cellular metabolism

  • ArthronPulse Vs Conventional Medical Devices

    ArthronPulse employs magnetic force, a non-invasive treatment technology, as opposed to conventional wellness medical devices that use ultrasound and low frequency. This allows ArthronPulse to deliver physical energy deep into tissues without interference from mediums like bones, resulting in superior therapeutic effects. By integrating low-level laser therapy, it can offer combined treatment benefits.

    Additionally, ArthronPulse utilizes patented technology that delivers magnetic force over long distances with low power consumption. This makes it smaller and more portable than PEFM (Pulsed Electromagnetic Field Therapy) devices used in hospitals and clinics, enhancing convenience for transportation and mobility.

  • ArthronPulse Vs Conventional Pharmaceuticals/Procedures/Surgical Treatments

    The anti-inflammatory and pain-relief effects of ArthronPulse can serve as an alternative to anti-inflammatory medicines like steroids, which carry inherent risks of side effects. Consistent management of joint inflammation with ArthronPulse can meet the objective of current pharmaceuticals and treatment technologies, which aim to "slow the progression of degenerative arthritis."
    Additionally, ArthronPulse can enhance the prognosis of cartilage stem cell therapy and increase the duration of its efficacy.